Treatment discordance in the utilization of neck dissection for stage I‐II supraglottic tumors.

Background: In 2018, the National Comprehensive Cancer Network treatment guidelines began recommending the use of neck dissection during surgical management of stage I‐II supraglottic laryngeal squamous cell carcinoma (LSCC). Methods: Trends and factors associated with the use of neck dissection during larynx‐preserving surgery for patients with cT1‐2, N0, M0 supraglottic LSCC in the National Cancer Database (2004–2020) were evaluated using multivariable‐adjusted logistic regression. Results: Of the 2080 patients who satisfied study eligibility criteria, 633 (30.4%) underwent neck dissection. Between 2018 and 2020, the rate of neck dissection was 39.0% (114/292). After multivariable adjustment, academic facility type, undergoing biopsy prior to surgery, and more radical surgery were significant predictors of receiving neck dissection. Conclusions: The results of this national analysis suggest that the utilization of guideline‐concordant neck dissection for management of stage I‐II supraglottic LSCC remains low and highlight the need to promote the practice of neck dissection for this patient population. [ABSTRACT FROM AUTHOR]